Ghaznavi Habib, Afzalipour Reza, Khoei Samideh, Sargazi Saman, Shirvalilou Sakine, Sheervalilou Roghayeh
Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Cancer Cell Int. 2024 May 7;24(1):160. doi: 10.1186/s12935-024-03331-3.
In recent times, the intersection of nanotechnology and biomedical research has given rise to nanobiomedicine, a captivating realm that holds immense promise for revolutionizing diagnostic and therapeutic approaches in the field of cancer. This innovative fusion of biology, medicine, and nanotechnology aims to create diagnostic and therapeutic agents with enhanced safety and efficacy, particularly in the realm of theranostics for various malignancies. Diverse inorganic, organic, and hybrid organic-inorganic nanoparticles, each possessing unique properties, have been introduced into this domain. This review seeks to highlight the latest strides in targeted glioblastoma therapy by focusing on the application of inorganic smart nanoparticles. Beyond exploring the general role of nanotechnology in medical applications, this review delves into groundbreaking strategies for glioblastoma treatment, showcasing the potential of smart nanoparticles through in vitro studies, in vivo investigations, and ongoing clinical trials.
近年来,纳米技术与生物医学研究的交叉融合催生了纳米生物医学,这是一个引人入胜的领域,有望彻底改变癌症领域的诊断和治疗方法。生物学、医学和纳米技术的这种创新融合旨在创造出安全性和有效性更高的诊断和治疗药物,尤其是在针对各种恶性肿瘤的诊疗一体化领域。各种无机、有机以及有机 - 无机杂化纳米粒子,各自具有独特的性质,已被引入到这个领域。本综述旨在通过聚焦无机智能纳米粒子的应用,突出胶质母细胞瘤靶向治疗的最新进展。除了探讨纳米技术在医学应用中的一般作用外,本综述还深入研究了胶质母细胞瘤治疗的突破性策略,通过体外研究、体内研究以及正在进行的临床试验展示了智能纳米粒子的潜力。
Cancer Cell Int. 2024-5-7
Front Chem. 2022-4-12
Recent Pat Nanotechnol. 2025
Int J Mol Sci. 2018-10-24
Discov Nano. 2023-12-20
Neurosurg Clin N Am. 2012-6-14
Front Oncol. 2025-8-11
ACS Appl Mater Interfaces. 2025-6-18
Pharmaceutics. 2024-7-15
Pharmaceutics. 2024-1-11
J Cancer Res Clin Oncol. 2023-8
Pharmaceutics. 2023-3-22
Nanomaterials (Basel). 2022-7-18